“life-science” Archives

Entry Author Date Location
Endomag, European Device Makers Eye U.S. Amid Regulatory Changes 10/20/16 Texas
The Power of the Cloud for Life Science R&D 10/19/16 Boston
Veritas Genetics Lands $30M for $1,000 Genome Sequencing 10/17/16 Boston
Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD 10/13/16 Boston
Inspyr Leaves San Antonio for California to Be Near Clinical Trials 10/12/16 Texas
BioBridge Plans to Grow $7.8M into Large-Scale Stem Cell Production 10/03/16 Texas
Caribou CEO Touts Incubator’s Role Translating Science into Startup 09/29/16 Texas
Progenerative Plans Bone, Business Growth From Revived Acelity Tech 09/22/16 Texas
After $70M Boston Scientific Deal, CeloNova CEO Heads to Nonprofit 09/19/16 Texas
For Fledgling San Antonio Companies, Startup Resources Trickling In 09/13/16 Texas
Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results 09/07/16 San Diego
Cepheid, Propelled By Seattle Chemists, Sells to Danaher for $4B 09/06/16 San Francisco
With Scaffold for Regenerating Arteries, Cardiovate Raises $350,000 09/01/16 Texas
Path Cleared for Bluegrass Vascular’s Vein-Access Device in Europe 08/30/16 Texas
Leap Therapeutics Seeks Public Markets With Macrocure Merger 08/29/16 Boston
Amylyx Nabs $5M to Take Aim at Nerve Cell Death in ALS Patients 08/22/16 Boston
San Antonio Life Science Executives Plan Medtech Product Workshops 08/22/16 Texas
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
Governments Pay for Research, Jobs in San Antonio Tech and Science 08/18/16 Texas
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
Rare Drug Developer Chiasma Lays Off More Workers After FDA Impasse 08/16/16 Boston
Inspyr Seeks Clinical Partner for Cash After New Name, Exec Hires 08/09/16 Texas
Metis Foundation, Targeting Military Researchers, Plans Fund Raise 08/05/16 Texas
Inspyr, Formerly GenSpera, Replaces Co-Founder Dionne With New CEO 08/04/16 Texas
Bioz, Using Machine Learning to Optimize Biology, Launches With $3M 07/20/16 San Francisco
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure 07/18/16 San Diego
Xbiotech Responds to ESMO, Other Critics of Phase 3 Cancer Data 07/15/16 Texas
Second Genome Replaces DiLaura as CEO, Brings Series B to $51M 07/13/16 San Francisco
San Antonio’s StemBioSys Brings Product to South Korea With SeouLin 07/12/16 Texas
Page 1 of 5 next page »